# US 2010/0166834 A1 · Preparations based on fibrinogen and sulfated polysaccharides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0166834 A1
- Document ID: US20100166834A1
- Status: Published application
- Kind: A1
- Application number: 12/636,620
- Filed: 2009-12-11
- Published: 2010-07-01
- Earliest claimed: 2008-12-11
- Assignees: Baxter International Inc.; Baxter Healthcare S.A.
- Inventors: Michael Dockal; Friedrich Scheiflinger; Hans Christian Hedrich; Klaus Tschetschkowitsch
- Web page: https://patentgrep.com/patent/US20100166834A1

## CPC

- A61L 24/106: {Fibrin; Fibrinogen}
- A61L 24/043: {Mixtures of macromolecular materials}
- A61P 7/04: Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A61P 41/00: Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A61L 2400/04: Materials for stopping bleeding
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides a preparation comprising fibrinogen and a sulfated polysaccharide as a one component composition or as a kit of parts comprising fibrinogen and sulfated polysaccharide as separated components. The present invention further provides a fibrin clot like structure obtainable by a defined process, a hemostatic patch, a two-component syringe system and various uses of the described preparations, fibrin clot like structures and patches.

## Claims

### Claim 1

A preparation comprising fibrinogen and a sulfated polysaccharide as a one component composition or as a kit of parts comprising fibrinogen and sulfated polysaccharide as separated components.

### Claim 2 (depends on 1)

A fibrin clot like structure obtainable by a process comprising the steps of
(a) providing a preparation of claim 1 as a solution,
(b) providing a cation containing solution as a separate component, optionally containing thrombin, or as a solution together with the sulfated polysaccharide component of claim 1, optionally containing thrombin,
(c) optionally providing a thrombin solution, and
(d) mixing (a) and (b) and optionally (c) either simultaneously or subsequently in any order so that a fibrin clot like structure is obtained.

### Claim 3

A hemostatic patch comprising
(1) a carrier, and
(2) at least one hemostatic agent which is a sulfated polysaccharide,
wherein, if the carrier is a sulfated polysaccharide, it is not the same sulfated polysaccharide as the hemostatic agent.

### Claim 4 (depends on 3)

The hemostatic patch of claim 3, wherein the carrier is a biocompatible material selected from the group consisting of collagen, gelatin, fibrinogen, fibrin, and a polysaccharide, or derivatives or mixtures thereof.

### Claim 5 (depends on 1)

A two-component syringe system comprising
EITHER
(a) the one component composition of claim 1 in the first barrel, and
(b) a cation containing preparation, optionally together with thrombin, in the second barrel;
OR
(a″) the separated sulfated polysaccharide of claim 1 and a cation-containing preparation, optionally together with thrombin in the first barrel, and
(b′) a fibrinogen preparation in the second barrel.

### Claim 6 (depends on 1, 2, 3)

Use of a preparation of claim 1, a fibrin clot like structure of claim 2 or a patch of claim 3 or for enhancing hemostasis.

### Claim 7 (depends on 1, 2, 3)

Use of a preparation of a preparation of claim 1, a fibrin clot like structure of claim 2 or a patch of claim 3 for wound healing.

### Claim 8 (depends on 1, 2, 3)

Use of a preparation of claim 1, a fibrin clot like structure of claim 2 or a patch of claim 3 as a drug delivery system.

### Claim 9 (depends on 1, 2, 3)

A method of tissue sealing or tissue gluing comprising applying on a wound surface a preparation of claim 1, a fibrin clot like structure of claim 2 or a patch of claim 3.
